InvestorsHub Logo
Followers 40
Posts 6074
Boards Moderated 1
Alias Born 06/29/2011

Re: biotech_researcher post# 12874

Tuesday, 06/15/2021 12:20:11 AM

Tuesday, June 15, 2021 12:20:11 AM

Post# of 17510
BR, I can live with that, although I think it will fetch more than that given the fact that it has a 16 year patent life and nobody in sight to compete with this unmet medical need drug, so they will have a kind of monopoly for LN in the next several years. The prospective buyer can pursue SLE, VOS, and other cyclosporine treated conditions. They can’t go wrong with a proven stellar drug. It won’t be long, yeah…
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News